Calix (CALX) insider exercises 10,000 stock options at $12.63
Calix, Inc. director and 10% owner Carl Russo reported exercising a stock option for 10,000 shares of common stock on 11/17/2025 at an exercise price of $12.63 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Calix, Inc. director and 10% owner Carl Russo reported exercising a stock option for 10,000 shares of common stock on 11/17/2025 at an exercise price of $12.63 per share. After this transaction, he directly owns 3,963,070 shares of Calix common stock. He also reports indirect holdings of 1,694,188 shares held by The Crescentico Trust, for which he is trustee, and 13,782 shares held by Equanimous Investments, where he and another individual may share voting and investment power. Following the option exercise, Russo still holds 590,000 stock options exercisable for Calix common stock, with an expiration date of 05/22/2030, and the shares subject to this option were fully vested and exercisable as of 05/22/2024.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (right to buy) | 10,000 | $0.00 | $0.00 |
| Exercise | Common Stock | 10,000 | $12.63 | $126K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (3)
- F1. Shares held by The Crescentico Trust, Carl Russo, Trustee.
- F2. Shares held by Equanimous Investments. The managing members of Equanimous Investments are Carl Russo and Tim Pasquinelli. These individuals may be deemed to have shared voting and investment power over the shares held by Equanimous Investments. Each of these individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.
- F3. 100% of the shares subject to the option were fully vested and exercisable on May 22, 2024.
AI-generated analysis. How Rhea-AI works. Not financial advice.